Big news for anyone touched by Alzheimer’s: two new FDA-approved drugs, Leqembi and Kisunla, are changing the game. They don’t cure dementia, but they do slow down memory loss by actually targeting the root cause—those nasty amyloid plaques in the brain. Both are pricey, but Medicare covers most of the cost. Early treatment is key, and while there are some side effects, these meds are the closest thing to hope we’ve seen in a while. #Health #BodyHealth #Alzheimers